ACTINIUM PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/15d4ddbd-940d-4011-91d9-bf31f4e7c996/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-36.2M | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-036504 |
| FY 2024 | $-42.1M | 2024-01-01 – 2024-12-31 | evidence 0001213900-25-026371 |
| FY 2023 | $-51.9M | 2023-01-01 – 2023-12-31 | evidence 0001213900-24-028038 |
| FY 2022 | $-34.1M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-025597 |
| FY 2021 | $-25.0M | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-015208 |
| FY 2020 | $-22.4M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-019297 |
| FY 2019 | $-22.1M | 2019-01-01 – 2019-12-31 | evidence 0001213900-21-019297 |
| FY 2018 | $-23.8M | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-004269 |
| FY 2017 | $-26.9M | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-003091 |
| FY 2016 | $-26.8M | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-002461 |
| FY 2015 | $-24.8M | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-011534 |
| FY 2014 | $-22.5M | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-001800 |
| FY 2013 | $-65.5M | 2000-06-14 – 2014-03-31 | evidence 0001213900-14-003153 |
| FY 2012 | $-56.8M | 2000-06-14 – 2013-03-31 | evidence 0001213900-13-002615 |
| FY 2011 | $-3.3M | 2011-01-01 – 2011-12-31 | evidence 0001213900-13-001417 |
| FY 2010 | $-26.1k | 2010-01-01 – 2010-12-31 | evidence 0001078782-12-001008 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ACTINIUM PHARMACEUTICALS, INC. — all facts · Revenue · Net Income